Why it was recalled
Lack of Assurance of Sterility
Product description
QUAD3 (PAP/PHEN/ALPRO/ATRO) 30 mg/3 mg/30 mcg/0.1mL Injectable, a) 2 mL and 5 mL vials, Compounded by Wells Pharmacy, Ocala, FL
Lot numbers, UPCs & expiration codes
All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry. a) Known lot code: 03292016@12, 0422016@10, 04222016@10, 05052016@33, 05122016@11, 05132016@19, 05242016@2, 06212016@17, 07262016@36, 09072016@21, 09142015@17 b) Known lot code: 03242016@9, 04112016@10, 04212016@19, 05042016@20, 05132016@21, 05202016@71, 06152016@7, 07122016@21, 08032016@17, 09092016@35.
Where it was sold
Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0330-2017
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Sep 21, 2016
- FDA report date
- Jan 11, 2017
- Quantity
- a) 1,312 vials and b) 3,354 vials
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Wells Pharmacy Network LLC
Original FDA data
Every field from FDA enforcement report D-0330-2017, exactly as published.
Show all FDA fields
- City
- Ocala
- State
- FL
- Status
- Terminated
- Country
- United States
- Event ID
- 75289
- Address
- 1210 SW 33rd Ave
- Code information
- All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry. a) Known lot code: 03292016@12, 0422016@10, 04222016@10, 05052016@33, 05122016@11, 05132016@19, 05242016@2, 06212016@17, 07262016@36, 09072016@21, 09142015@17 b) Known lot code: 03242016@9, 04112016@10, 04212016@19, 05042016@20, 05132016@21, 05202016@71, 06152016@7, 07122016@21, 08032016@17, 09092016@35.
- Postal code
- 34474-2853
- Report date
- Jan 11, 2017
- Product type
- Drugs
- Recall number
- D-0330-2017
- Classification
- Class II
- Recalling firm
- Wells Pharmacy Network LLC
- Product quantity
- a) 1,312 vials and b) 3,354 vials
- Termination date
- Jul 2, 2021
- Reason for recall
- Lack of Assurance of Sterility
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- QUAD3 (PAP/PHEN/ALPRO/ATRO) 30 mg/3 mg/30 mcg/0.1mL Injectable, a) 2 mL and 5 mL vials, Compounded by Wells Pharmacy, Ocala, FL
- Distribution pattern
- Nationwide
- Recall initiation date
- Sep 21, 2016
- Initial firm notification
- Press Release
- Center classification date
- Jan 4, 2017